← Back
Data updated: Mar 10, 2026
I 3 PHARMS
ImmunologyInfectious DiseaseCardiovascular
I 3 PHARMS is a generic drug manufacturer focused on Immunology, Infectious Disease, Cardiovascular. Key products include TRANEXAMIC ACID.
2023
Since
4
Drugs
-
Trials
30
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
TRANEXAMIC ACID 2026-01-26
MARAVIROC 2025-11-04
POSACONAZOLE 2025-10-29
Manufacturing (CMC)
TRANEXAMIC ACID 2025-08-20
Labeling
TRANEXAMIC ACID 2025-08-19
POSACONAZOLE 2025-07-10
Labeling
POSACONAZOLE 2025-07-03
Labeling
POSACONAZOLE 2025-07-02
Labeling
TRANEXAMIC ACID 2025-06-11
TRANEXAMIC ACID 2025-06-09
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Immunology 33%
1 drugs
Infectious Disease 33%
1 drugs
Cardiovascular 33%
1 drugs
Pipeline Strength Pro
Loading...
Competitors Pro
Merck big-pharma
Infectious Disease, Cardiovascular, Immunology
Johnson & Johnson big-pharma
Immunology, Infectious Disease, Cardiovascular
COSETTE other
Cardiovascular, Infectious Disease, Immunology
BAUSCH AND LOMB specialty
Cardiovascular, Infectious Disease, Immunology
Pfizer big-pharma
Infectious Disease, Immunology
Discontinued (0)
Company Info
- First Approval
- 2023-08-17
- Latest
- 2026-01-26
- Applications
- 4